Physician
Tristan Medical Enterprises PC
Tristan Medical Enterprises PC was paid $1.87M by Medicaid between Jan 2018 and Dec 2024, across 59 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoTRISTAN MEDICAL ENTERPRISES PC
NORTH ATTLEBORO, MA 02760
NORTH ATTLEBORO, MA 02760
33aNPI1538398326assigned 07/14/2009
33bProvider typeFamily Medicine Physician
28Total paid$1.87M
24GClaims58,881
24DCodes billed59
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Massachusetts
Rank by total paid#11 of 744
Median peer was paid$10K
This provider vs. median179×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,705 | $372K | |
| 2019 | 7,045 | $291K | |
| 2020 | 7,627 | $305K | |
| 2021 | 7,661 | $301K | |
| 2022 | 9,306 | $355K | |
| 2023 | 9,433 | $165K | |
| 2024incomplete | 8,104 | $79K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 16,493 | 15,402 | $670K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 7,574 | 7,108 | $485K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.6% | 4,747 | 4,683 | $85K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.5% | 1,072 | 1,071 | $64K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3.4% | 1,322 | 1,312 | $63K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.1% | 978 | 978 | $59K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.1% | 1,002 | 1,002 | $58K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.6% | 824 | 807 | $48K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.3% | 728 | 728 | $43K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.3% | 4,506 | 4,497 | $43K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.3% | 4,118 | 4,106 | $42K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 1,397 | 1,310 | $29K |
47 more codes
| 17110 | 1.3% | 497 | $24K | |
| 99173 | 1.2% | 2,032 | $22K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 883 | $21K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 1,569 | $20K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 307 | $14K |
| 90461 | <1% | 1,975 | $11K | |
| 96127 | <1% | 1,270 | $11K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 312 | $10K |
| 86769 | <1% | 236 | $8K | |
| 11100 | <1% | 97 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 428 | $3K |
| 87420 | <1% | 196 | $2K | |
| 17004 | <1% | 41 | $2K | |
| 87070 | <1% | 250 | $2K | |
| 94760 | <1% | 974 | $2K | |
| 99188 | <1% | 79 | $2K | |
| 87276 | <1% | 141 | $2K | |
| 87275 | <1% | 139 | $2K | |
| 11102 | <1% | 29 | $2K | |
| 11301 | <1% | 27 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 52 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 52 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 99 | $1K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $1K |
| 83655 | <1% | 83 | $1K | |
| 99050 | <1% | 57 | $927.36 | |
| 11300 | <1% | 14 | $667.30 | |
| 81003 | <1% | 329 | $635.25 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 24 | $453.96 |
| 90688 | <1% | 27 | $398.20 | |
| 94664 | <1% | 26 | $375.62 | |
| ATP03 | <1% | 47 | $321.95 | |
| 0003A | <1% | 12 | $321.09 | |
| 90674 | <1% | 12 | $253.17 | |
| 99072 | <1% | 1,255 | $194.83 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $60.06 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 35 | $32.15 |
| 99000 | <1% | 75 | $31.90 | |
| 90686 | <1% | 96 | $19.03 | |
| 90651 | 0% | 14 | $0.00 | |
| 90698 | 0% | 45 | $0.00 | |
| 36416 | 0% | 13 | $0.00 | |
| 90680 | 0% | 30 | $0.00 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 0% | 13 | $0.00 |
| 90670 | 0% | 151 | $0.00 | |
| 80061 | Lipid panel | 0% | 34 | $0.00 |
| 90685 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWELTER, RYAN (OWNER)